Search results
Merck & Co Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 5 months agoMerck & Co Inc (NYSE:MRK) recently announced a dividend of $0.77 per share, payable on 2024-01-08, with the ex-dividend date set for 2023-12-14. As...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 weeks agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies
Reuters via Yahoo News· 1 year agoEbola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and...
Merck (MRK) Beats on Q3 Earnings & Revenues, Ups 2022 View
Zacks via Yahoo Finance· 2 years agoMerck & Co., Inc. MRK reported third-quarter 2022 adjusted earnings of $1.85 per share, beating the...
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
Benzinga via Yahoo Finance· 1 year agoEbola vaccines developed by Johnson & Johnson (NYSE: JNJ) and Merck & Co Inc (NYSE: MRK) produced...
Merck To Start Pivotal Trial For Next-Gen Pneumococcal Vaccine Next Month
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) presented results from the Phase 1/2 study, evaluating V116 in...
Why Merck Stock Is Trading Higher Today
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc's (NYSE: MRK) Q1 sales reached $14.49 billion, down 9% Y/Y, beating the consensus of $13.79 billion. Excluding Lagevrio (COVID-19...
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Reuters via Yahoo News· 11 months agoAdding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the...
Beat the Dow Jones With This Unstoppable Dividend Stock
Motley Fool· 2 years agoPharmaceutical giant Merck & Co. (NYSE: MRK) spun off its women's health and biosimilars divisions,...
Merck gets FDA decision date for new pneumococcal vaccine
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: The Food and Drug Administration has granted a priority review to Merck & Co.’s...
